Clinical Report: Multi-Ancestry Polygenic Risk Scores for Type 2 Diabetes
Overview
Multi-ancestry polygenic risk scores (PRSs) significantly enhance the prediction of type 2 diabetes across diverse ancestry groups, outperforming traditional clinical factors. The study involved nearly 2 million participants, revealing that higher PRS values correlate with increased odds of developing diabetes and related complications.
Background
Diabetes is a major global health concern, with type 2 diabetes (T2D) posing significant morbidity and mortality risks. Traditional risk assessment methods primarily focus on clinical factors and glycemia, often neglecting genetic predispositions. The integration of polygenic risk scores into risk stratification may provide a more nuanced understanding of diabetes risk across diverse populations.
Data Highlights
| Population | Odds Ratio (97.5th vs Interquartile) |
|---|---|
| African or African American | 3.43 |
| Admixed American | 7.47 |
| East Asian | 6.62 |
| European | 6.25 |
| South Asian | 4.50 |
Key Findings
- Multi-ancestry PRSs showed larger effect sizes than single-ancestry PRSs across all groups.
- Odds of type 2 diabetes increased significantly with higher PRS values, particularly at the extremes of the distribution.
- Predictive performance varied by ancestry, with European and East Asian populations showing the strongest discrimination.
- Higher PRS values were associated with earlier onset of type 2 diabetes by up to 2.3 years.
- Participants with normal glucose but high PRS had similar diabetes-free survival risks as those with elevated glucose in the lowest PRS tertile.
Clinical Implications
Incorporating multi-ancestry PRSs into clinical practice may enhance diabetes risk stratification, particularly in diverse populations. Clinicians should consider genetic risk alongside traditional factors to identify individuals at higher risk for developing type 2 diabetes and its complications.
Conclusion
The findings underscore the potential of multi-ancestry polygenic risk scores to improve diabetes risk assessment and highlight the need for further validation in clinical settings.
Related Resources & Content
- Broad Institute, Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries, 2026
- American Diabetes Association, Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026, 2026
- The Pathologist, Diabetes Risk Assessment: A New Approach, 2026
- AACE Endocrine AI, AI tool predicts hypoglycemia risk pre-exercise, 2026
- European Journal of Preventive Cardiology, Cardiovascular health scores as predictors. Where to go next?, 2026
- European Journal of Preventive Cardiology — External Assessment of Cardiovascular Risk Assessment Models in Type 2 Diabetes Patients Utilizing the CARDIANA Cohort from Spain
- 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026 - PMC
- Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries. | Broad Institute
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
